RACIOPPI, LUIGI
RACIOPPI, LUIGI
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Serum withdrawal induces apoptotic cell death in Ki-ras transformed but not in normal differentiated thyroid cells.
1995 DI JESO, B.; Ulianich, L.; Racioppi, Luigi; D'Armiento, FRANCESCO PAOLO; Feliciello, Antonio; Pacifico, F.; Consiglio, E.; Formisano, S.
Mycoplasma and tumors: synergistic effect on human monocyte-derived dendritic cells immunosuppressing activity
2008 Racioppi, Luigi
HLA Class II molecules on monocytes regulate T cell proliferation through phisical interaction in the CD3 activation pathway
1991 D'Oro, U.; DI ROSA, F.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, A. M.; Chianca, R.; Ferrone, S.; Zappacosta, S.; Fontana, S.
Serum withdrawal induces apoptotic cell death in KI-ras transformed but not in normal differentiated thyroid cells.
1995 DI JESO, B.; Ulianich, L.; Racioppi, Luigi; D'Armiento, FRANCESCO PAOLO; Feliciello, A.; Pacifico, F.; Consiglio, E.; Formisano, Silvestro
Modulation of CD45 tyrosine phosphatase activity by antigen.
2001 LAGO PAZ, F; Galgani, M; D'Oro, U; Matarese, G; Masci, Am; Zappacosta, S; Racioppi, Luigi
The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling
1996 Racioppi, Luigi; Matarese, M; D'Oro, U; DE PASCALE, Mt; Masci, Am; Fontana, S.; Zappacosta, S.
The molecular basis of class II MHC allelic control of T cell responses.
1991 Racioppi, Luigi; Ronchese, F; Schwartz, Rh; Germain, Rn
The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
1993 Boehncke, Wh; Takeshita, T; Pendleton, Cd; Houghten, Ra; SADEGH NASSERI, S; Racioppi, Luigi; Berzofsky, Ja; Germain, Rn
HLA class II molecules transduce accessory signals affecting the CD3, but not IL-2 activation pathaway in T blast.
1993 Di Rosa, F.; D’Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Ferrone, S.; Fontana, S.; Zappacosta, S.
ANALYSIS OF TCR BV REPERTOIRE IN HUMAN PANCREATIC ADENOCARCINOMA
2002 Masci, Am; Vitiello, L; Piemonte, L; DI CARLO, V; Racioppi, Luigi; L., Racioppi
Fatal rapidly progressive liver disease associated to a novel mutation of the perforin gene.
2002 Busiello, Rosanna; Fecarotta, Simona; Giordano, G.; Ursini, M. V.; Galgani, M.; Racioppi, Luigi; Pignata, Claudio
Allogeneic transplantation of in vitro cultured thymic tissue purged of hematopoietic cells in a DiGeorge patient.
2002 Pignata, Claudio; Matrecano, Eliana; Settimi, Alessandro; Timelis, S.; Vitiello, L.; Coppola, D.; Buonomo, T.; Cimini, Vincenzo; Racioppi, Luigi
Abnormal tyrosine phosphorylated 30 kDa protein in a patient with immunodeficiency and severe encephalopathy associated with a constitutive activation of the MAPK cascade.
1996 Gaetaniello, L.; Scotese, I.; Matarese, Giuseppe; De Filippo, S.; Racioppi, Luigi; Pignata, Claudio
Role of Calcium/Calmodulin Dependent Kinase Kinase 2in Acute Radiation Syndrome. National Institutes of Health Pilot Grants Radccore 5U19-AI067798-07 (PI Luigi Racioppi).
2011 Racioppi, Luigi
FOXN1 mutation abrogates pre-natal T-cell development in humans
2010 Amorosi, S.; Gorrese, M.; Fusco, A.; Vitiello, L.; Panico, L.; Vigliano, I.; Ursini, M. V.; Racioppi, Luigi; DEL VECCHIO, Luigi; Pignata, Claudio
Inflammation & Allergy - Drug Targets
2010 Racioppi, Luigi
Journal of Clinical Trials
2011 Racioppi, Luigi
Studio dei clonotipilinfocitari dopo trapianto di isole pancreatiche.
2010 Racioppi, Luigi
Constitutive activation of the 42 kDa MAPK in a patient with immunodeficiency and severe encephalopathy
1996 Gaetaniello, L; Scotese, I; DEL GIUDICE, Ennio; Matarese, Giuseppe; De Filippo, S; Racioppi, Luigi; Pignata, Claudio
Phase II monitored clinical trial for evaluation of treatment of patients with Thymic Epithelial Tumours (TET) or Histiocitosi X (LCH) with Imatinib Mesylate.
2008 Racioppi, Luigi
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Serum withdrawal induces apoptotic cell death in Ki-ras transformed but not in normal differentiated thyroid cells. | 1.1 Articolo in rivista | 1995 | DI JESO, B.; Ulianich, L.; Racioppi, Luigi; D'Armiento, FRANCESCO PAOLO; Feliciello, Antonio; Pacifico, F.; Consiglio, E.; Formisano, S. | |
| Mycoplasma and tumors: synergistic effect on human monocyte-derived dendritic cells immunosuppressing activity | 8.10 Tesi di Dottorato | 2008 | Racioppi, Luigi | |
| HLA Class II molecules on monocytes regulate T cell proliferation through phisical interaction in the CD3 activation pathway | 2.1 Contributo in volume (Capitolo o Saggio) | 1991 | D'Oro, U.; DI ROSA, F.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, A. M.; Chianca, R.; Ferrone, S.; Zappacosta, S.; Fontana, S. | |
| Serum withdrawal induces apoptotic cell death in KI-ras transformed but not in normal differentiated thyroid cells. | 1.1 Articolo in rivista | 1995 | DI JESO, B.; Ulianich, L.; Racioppi, Luigi; D'Armiento, FRANCESCO PAOLO; Feliciello, A.; Pacifico, F.; Consiglio, E.; Formisano, Silvestro | |
| Modulation of CD45 tyrosine phosphatase activity by antigen. | 1.1 Articolo in rivista | 2001 | LAGO PAZ, F; Galgani, M; D'Oro, U; Matarese, G; Masci, Am; Zappacosta, S; Racioppi, Luigi | |
| The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling | 1.1 Articolo in rivista | 1996 | Racioppi, Luigi; Matarese, M; D'Oro, U; DE PASCALE, Mt; Masci, Am; Fontana, S.; Zappacosta, S. | |
| The molecular basis of class II MHC allelic control of T cell responses. | 1.1 Articolo in rivista | 1991 | Racioppi, Luigi; Ronchese, F; Schwartz, Rh; Germain, Rn | |
| The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. | 1.1 Articolo in rivista | 1993 | Boehncke, Wh; Takeshita, T; Pendleton, Cd; Houghten, Ra; SADEGH NASSERI, S; Racioppi, Luigi; Berzofsky, Ja; Germain, Rn | |
| HLA class II molecules transduce accessory signals affecting the CD3, but not IL-2 activation pathaway in T blast. | 1.1 Articolo in rivista | 1993 | Di Rosa, F.; D’Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Ferrone, S.; Fontana, S.; Zappacosta, S. | |
| ANALYSIS OF TCR BV REPERTOIRE IN HUMAN PANCREATIC ADENOCARCINOMA | 1.1 Articolo in rivista | 2002 | Masci, Am; Vitiello, L; Piemonte, L; DI CARLO, V; Racioppi, Luigi; L., Racioppi | |
| Fatal rapidly progressive liver disease associated to a novel mutation of the perforin gene. | 1.5 Abstract in rivista | 2002 | Busiello, Rosanna; Fecarotta, Simona; Giordano, G.; Ursini, M. V.; Galgani, M.; Racioppi, Luigi; Pignata, Claudio | |
| Allogeneic transplantation of in vitro cultured thymic tissue purged of hematopoietic cells in a DiGeorge patient. | 1.5 Abstract in rivista | 2002 | Pignata, Claudio; Matrecano, Eliana; Settimi, Alessandro; Timelis, S.; Vitiello, L.; Coppola, D.; Buonomo, T.; Cimini, Vincenzo; Racioppi, Luigi | |
| Abnormal tyrosine phosphorylated 30 kDa protein in a patient with immunodeficiency and severe encephalopathy associated with a constitutive activation of the MAPK cascade. | 1.5 Abstract in rivista | 1996 | Gaetaniello, L.; Scotese, I.; Matarese, Giuseppe; De Filippo, S.; Racioppi, Luigi; Pignata, Claudio | |
| Role of Calcium/Calmodulin Dependent Kinase Kinase 2in Acute Radiation Syndrome. National Institutes of Health Pilot Grants Radccore 5U19-AI067798-07 (PI Luigi Racioppi). | 8.07 Progetti di Ricerca Finanziati | 2011 | Racioppi, Luigi | |
| FOXN1 mutation abrogates pre-natal T-cell development in humans | 1.5 Abstract in rivista | 2010 | Amorosi, S.; Gorrese, M.; Fusco, A.; Vitiello, L.; Panico, L.; Vigliano, I.; Ursini, M. V.; Racioppi, Luigi; DEL VECCHIO, Luigi; Pignata, Claudio | |
| Inflammation & Allergy - Drug Targets | 8.06 Partecip. Editorial Board di riviste scientifiche | 2010 | Racioppi, Luigi | |
| Journal of Clinical Trials | 8.06 Partecip. Editorial Board di riviste scientifiche | 2011 | Racioppi, Luigi | |
| Studio dei clonotipilinfocitari dopo trapianto di isole pancreatiche. | 8.07 Progetti di Ricerca Finanziati | 2010 | Racioppi, Luigi | |
| Constitutive activation of the 42 kDa MAPK in a patient with immunodeficiency and severe encephalopathy | 8.02 Comunicazioni a Convegni o Seminari | 1996 | Gaetaniello, L; Scotese, I; DEL GIUDICE, Ennio; Matarese, Giuseppe; De Filippo, S; Racioppi, Luigi; Pignata, Claudio | |
| Phase II monitored clinical trial for evaluation of treatment of patients with Thymic Epithelial Tumours (TET) or Histiocitosi X (LCH) with Imatinib Mesylate. | 8.03 Conv. e contr. di ricerca di Enti Pubblici/Privati | 2008 | Racioppi, Luigi |